Co-injection of MC38 and EGCs resulted in increased tumor growth associated with higher numbers of TAMs, as well as CD4+ T cells, CD8+ T cells, and Treg cells compared to mice orthotopically injected with MC38 cells alone (Fig. 1f, g and Supplementary Fig. 2c). The gene discussed is CD8A; the disease is neoplasm.